Cargando…
Tanshinone IIA and hepatocellular carcinoma: A potential therapeutic drug
Because of its high prevalence and poor long-term clinical treatment effect, liver disease is regarded as a major public health problem around the world. Among them, viral hepatitis, fatty liver, cirrhosis, non-alcoholic fatty liver disease (NAFLD), and autoimmune liver disease are common causes and...
Autores principales: | Li, Hu, Hu, Pengbo, Zou, Yajun, Yuan, Lijuan, Xu, Yucheng, Zhang, Xiaohui, Luo, Xiaoyan, Zhang, Zhiqiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9928209/ https://www.ncbi.nlm.nih.gov/pubmed/36798821 http://dx.doi.org/10.3389/fonc.2023.1071415 |
Ejemplares similares
-
Galactose-Modified PH-Sensitive Niosomes for Controlled Release and Hepatocellular Carcinoma Target Delivery of Tanshinone IIA
por: Hu, Xixi, et al.
Publicado: (2021) -
Tanshinone IIA suppress the proliferation of HNE-1 nasopharyngeal carcinoma an in vitro study
por: Zhou, Mingguang, et al.
Publicado: (2018) -
Effect of Supplementation of Tanshinone IIA and Sodium Tanshinone IIA Sulfonate on the Anticancer Effect of Epirubicin: An In Vitro Study
por: Chan, Szu-Erh, et al.
Publicado: (2011) -
Preparation and characterisation of solid dispersions of tanshinone IIA, cryptotanshinone and total tanshinones
por: Zhai, Xifeng, et al.
Publicado: (2017) -
Renoprotective Effects of Tanshinone IIA: A Literature Review
por: Chen, Zhengtao, et al.
Publicado: (2023)